A
A. C. Mesquita
Publications - 9
Citations - 900
A. C. Mesquita is an academic researcher. The author has contributed to research in topics: Type 2 diabetes & Population. The author has an hindex of 5, co-authored 9 publications receiving 845 citations.
Papers
More filters
Journal ArticleDOI
A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes
Bernhard Paulweber,Paul Valensi,Jaana Lindström,N. Lalic,Colin J Greaves,Martin McKee,K. Kissimova-Skarbek,Stavros Liatis,Emmanuel Cosson,Julia Szendroedi,K. E. Sheppard,Kate Charlesworth,A. M. Felton,M. Hall,A. Rissanen,A. Rissanen,Jaakko Tuomilehto,Peter Schwarz,Michael Roden,M. Paulweber,Andreas Stadlmayr,Lyudmyla Kedenko,Nicholas Katsilambros,Konstantinos Makrilakis,Zdravko Kamenov,Philip Evans,Aleksandra Gilis-Januszewska,K. Lalic,A. Jotic,P. Djordevic,V. Dimitrijevic-Sreckovic,U. Hühmer,B Kulzer,S. Puhl,Y. H. Lee-Barkey,Ala'a Alkerwi,Charles Abraham,Wendy Hardeman,Tania Acosta,Martin Adler,Noël C. Barengo,R. Barengo,J. M. Boavida,V. Christov,B. Claussen,Xavier Cos,S. Deceukelier,P. Djordjevic,Martin R. Fischer,R. Gabriel-Sanchez,Margalit Goldfracht,José Gómez,U. Handke,Hans Hauner,J. Herbst,Norbert Hermanns,L. Herrebrugh,C. Huber,J. Huttunen,S. Karadeniz,Mykola Khalangot,D. Köhler,Veronika Kopp,P. Kronsbein,D. Kyne-Grzebalski,Nebojsa Lalic,Rüdiger Landgraf,C. McIntosh,A. C. Mesquita,D. Misina,F. Muylle,Anne Neumann,A. C. Paiva,Pia Pajunen,Markku Peltonen,L. Perrenoud,Andreas Pfeiffer,Auli Polonen,F. Raposo,T. Reinehr,Clyde C. Robinson,Ulrike Rothe,T. Saaristo,J. Scholl,S. Spiers,T. Stemper,B. Stratmann,Zbigniew Szybiński,Tsvetalina Tankova,V. Telle-Hjellset,G. Terry,Daniel Tolks,F. Toti,A. Undeutsch,C. Valadas,Dzilda Velickiene,P. Vermunt,R. Weiss,Johan Wens,Temel Yilmaz +99 more
TL;DR: In this article, a European multidisciplinary consortium systematically reviewed the evidence on the effectiveness of screening and interventions for type 2 diabetes (T2DM) prevention using SIGN criteria, and provided evidence-based recommendations for preventing T2DM.
Journal ArticleDOI
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe.
Jaana Lindström,Anne Neumann,K. E. Sheppard,Aleksandra Gilis-Januszewska,Colin J Greaves,U. Handke,Pia Pajunen,S. Puhl,Auli Polonen,Aila Rissanen,Michael Roden,T. Stemper,V. Telle-Hjellset,Jaakko Tuomilehto,Dzilda Velickiene,Peter Schwarz,Tania Acosta,Martin Adler,Ala'a Alkerwi,Noël C. Barengo,R. Barengo,J. M. Boavida,Kate Charlesworth,V. Christov,B. Claussen,Xavier Cos,Emmanuel Cosson,S. Deceukelier,V. Dimitrijevic-Sreckovic,P. Djordjevic,Philip Evans,A. M. Felton,Martin R. Fischer,R. Gabriel-Sanchez,Margalit Goldfracht,José Gómez,M. Hall,Hans Hauner,J. Herbst,Norbert Hermanns,L. Herrebrugh,C. Huber,U. Hühmer,J. Huttunen,A. Jotic,Zdravko Kamenov,S. Karadeniz,Nicholas Katsilambros,Mykola Khalangot,Katarzyna Kissimova-Skarbek,D. Köhler,Veronika Kopp,P. Kronsbein,B Kulzer,D. Kyne-Grzebalski,K. Lalic,N. Lalic,Rüdiger Landgraf,Y. H. Lee-Barkey,Stavros Liatis,Konstantinos Makrilakis,C. McIntosh,Martin McKee,A. C. Mesquita,D. Misina,F. Muylle,A. C. Paiva,Bernhard Paulweber,Markku Peltonen,L. Perrenoud,Andreas Pfeiffer,F. Raposo,T. Reinehr,Clyde C. Robinson,Ulrike Rothe,T. Saaristo,J. Scholl,S. Spiers,B. Stratmann,Julia Szendroedi,Zbigniew Szybiński,Tsvetalina Tankova,G. Terry,Daniel Tolks,F. Toti,A. Undeutsch,C. Valadas,Paul Valensi,P. Vermunt,R. Weiss,Johan Wens,Temel Yilmaz +91 more
TL;DR: A comprehensive approach to diabetes prevention should combine population based primary prevention with programmes targeted at those who are at high risk, and take account of the local circumstances and diversity within modern society (e.g. social inequalities).
Journal ArticleDOI
First diabetes prevalence study in Portugal: PREVADIAB study
L. Gardete-Correia,J. M. Boavida,João Filipe Raposo,A. C. Mesquita,C. Fona,Rui Carvalho,S. Massano-Cardoso +6 more
TL;DR: In this paper, the prevalence of Type 2 diabetes and pre-diabetes in the Portuguese population aged between 20 and 79 years was determined, with a significant difference between men (14.2%) and women (9.5%) with a 95% confidence interval of 10.8-12.6%.
Journal ArticleDOI
Prevalence of chronic kidney disease and associated risk factors, and risk of end-stage renal disease: data from the PREVADIAB study.
José Vinhas,L. Gardete-Correia,J. M. Boavida,João Filipe Raposo,A. C. Mesquita,Maria Conceição Fona,Raquel Carvalho,Salvador Massano-Cardoso +7 more
TL;DR: The high incidence of ESRD among the Portuguese population is not due to a greater prevalence of CKD, and a higher rate of progression associated with the high prevalence of risk factors may account for the high incidence.
Journal ArticleDOI
Quality Indicators for the Prevention of Type 2 Diabetes in Europe – IMAGE
Pia Pajunen,Rüdiger Landgraf,F. Muylle,Anne Neumann,Jaana Lindström,Peter Schwarz,Markku Peltonen,Tania Acosta,Martin Adler,Ala'a Alkerwi,Noël C. Barengo,R. Barengo,J. M. Boavida,Kate Charlesworth,V. Christov,B. Claussen,Xavier Cos,Emmanuel Cosson,S. Deceukelier,V. Dimitrijevic-Sreckovic,P. Djordjevic,Philip Evans,A. M. Felton,Martin R. Fischer,R. Gabriel-Sanchez,Aleksandra Gilis-Januszewska,Margalit Goldfracht,José Gómez,Colin J Greaves,M. Hall,U. Handke,Hans Hauner,J. Herbst,Norbert Hermanns,L. Herrebrugh,C. Huber,U. Hühmer,J. Huttunen,A. Jotic,Zdravko Kamenov,S. Karadeniz,N. Katsilambros,Mykola Khalangot,Katarzyna Kissimova-Skarbek,D. Köhler,Veronika Kopp,P. Kronsbein,B Kulzer,D. Kyne-Grzebalski,K. Lalic,N. Lalic,Y. H. Lee-Barkey,Stavros Liatis,Konstantinos Makrilakis,C. McIntosh,Martin McKee,A. C. Mesquita,D. Misina,A. C. Paiva,B. Paulweber,L. Perrenoud,Andreas Pfeiffer,Auli Polonen,S. Puhl,F. Raposo,T. Reinehr,Aila Rissanen,Clyde C. Robinson,Michael Roden,Ulrike Rothe,T. Saaristo,J. Scholl,K. E. Sheppard,S. Spiers,T. Stemper,B. Stratmann,Julia Szendroedi,Zbigniew Szybiński,Tsvetalina Tankova,V. Telle-Hjellset,G. Terry,Daniel Tolks,F. Toti,Jaakko Tuomilehto,A. Undeutsch,C. Valadas,Paul Valensi,Dzilda Velickiene,P. Vermunt,R. Weiss,Johan Wens,Temel Yilmaz +91 more
TL;DR: The background and the methods used in the development of the IMAGE project quality indicators for diabetes primary prevention programs are described, which constitute the minimum level of quality assurance recommended for diabetes prevention programs.